A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)
Clinical trial NCT07699237 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07699237
- Sponsor
- University of Cologne
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2031-06-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.